El próximo día viernes 20 de noviembre a las 13:00 horas en el Aula de Grados Aula Magna de la Facultad de Medicina se organiza la conferencia perteneciente al ciclo de conferencias de IBIMA titulada “A successful journey through the Editorial Process”, que será impartida por el Prof. Dr. Mario U. Mondelli. Confiamos en vuestra participación. Mario U Mondelli, MD PhD FRCP (Lond), is Professor of Infectious Diseases at Pavia University and Head of the Research Laboratories, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. He is also Director of the Postgraduate School of Infectious and tropical Diseases of the University of Pavia. After graduating in Medicine summa cum laude in 1978 at the University of Milan, he spent 4 years in London as a Research Fellow and Honorary Registrar at the Liver Unit of King’s College Hospital and in the United States where he worked as Visiting Research Fellow and Research Associate for more than 2 years at the Scripps Research Institute of la Jolla, California. He received his PhD from the University of Pavia in 1988 upon his return from the US. He served the European Association for the Study of the Liver (EASL) as Secretary General from 1995 to 1997 and the Journal of Hepatology as Associate Editor and subsequently as Co-Editor between 1999 and 2009. He was also Associate Editor of the European Journal of Clinical Investigation (2010-2014) and currently Editor-in-Chief of Liver International and Academic Editor of PLoS ONE. He was member of the EASL Ethics Committee from 2011 to 2014 and Chairman of the United European Gastroenterology (UEG) in 2000. He is Immediate Past President of the International Association for the Study of the Liver (IASL), and has been President of the Infectious Diseases Section of the European Union of Medical Specialists from 2009 to 2015. The list of awards and apical positions attests to Prof. Mondelli’s leading ability and prestige. His research activity over the years has been characterized by a strong personal involvement in laboratory science (molecular virology and immunology in particular), together with clinical management of patients, moving from bench to bedside and back again. Prof. Mondelli has a longstanding tradition of clinical and translational research on viral hepatitis which is evident from several research articles published in the field. His scientific production is available at http://scholar.google.it/citations?user=JzUMPl4AAAAJ. He is listed as co-inventor in a patent of a human monoclonal antibody to the HCV NS3 helicase/NTPase domain. Additional research interests include the role of innate immunity in the control of HBV and HCV, the NK cell receptor dynamic profiles as biomarkers of response to antiviral therapy, and the production of neutralizing human monoclonal antibodies specific for HBV.